Skip to content

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Dispensing Evaluation of Lens Comfort and Subjective Vision of an Etafilcon A With Print and PVP Lens for Dark Eyes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01484054
Enrollment
103
Registered
2011-12-02
Start date
2011-11-30
Completion date
2012-02-29
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Ametropia

Brief summary

To evaluate and compare the performance of a new contact lens to a marketed contact lens.

Interventions

DEVICEetafilcon A with print and PVP for dark eyes (EAPVPDE)

A daily disposable contact lens

DEVICEetafilcon A control lens (EADE)

A marketed daily disposable contact lens

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 34 Years
Healthy volunteers
No

Inclusion criteria

* The subject must be a healthy adult at least 18 years of age and no more than 34 years of age. * The subjects must be female, dark eye Caucasian, Non-Hispanic habitual soft contact lens wearer (both eyes). * The subject rated the Concept Statement positively (i.e., a rating of 4 or 5). If not the subject is not eligible to participate. * The subject must have no known ocular or systemic allergies that might interfere with contact lens wear. * The subject must have no known systemic disease, or need for medication, which might interfere with contact lens wear. * The subject's optimal vertexed spherical equivalent distance correction must be between-1.00 and -4.00D. * Any cylinder power must be:\<=0.75D. * The subject must have visual acuity best correctable to 20/25 or better for each eye. * The subject must have normal eyes (no ocular medications or ocular infection of any type). * The subject must read and sign the Statement of Informed Consent. * The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion criteria

* Ocular or systemic allergies or disease which might interfere with contact lens wear. * Systemic disease, autoimmune disease, or use of medication which might interfere with contact lens wear. * Clinically significant (grade 3 or worse) corneal edema, corneal neovascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear. * Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear. * Any ocular infection. * Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear. * Any color deficiencies (color blindness) - to the best of the subject's knowledge. * Pregnancy or lactation. * Diabetes. * Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV). * Habitual contact lens type is toric, multifocal, or is worn as extended wear. * Subject presents with one dark iris color and one light iris color * Subject has heterochromia iridis (a difference in color between parts of one iris) * The subject is an employee or family member of the clinical study site.

Design outcomes

Primary

MeasureTime frameDescription
Subject Reported Overall Quality of Lens Vision Using the Contact Lens User Evaluation (CLUE) QuestionnaireAfter 7 to 9 days of lens wearThe overall quality of lens vision was assessed using the CLUE questionnaire after 7-9 days of follow-up. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range from 0-120.
Subject Reported Overall Lens Comfort Using the Contact Lens User Evaluation (CLUE) QuestionnaireAfter 7 to 9 days of lens wearThe overall lens comfort was assessed using the CLUE questionnaire after 7-9 days of follow-up.The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
Subject Reported Overall Lens Handling Using the Contact Lens User Evaluation (CLUE) QuestionnaireAfter 7 to 9 days of lens wearThe overall lens handling was assessed using the CLUE questionnaire after 7-9 days of follow-up. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Countries

United States

Participant flow

Pre-assignment details

Of those 103 enrolled subjects, 3 subjects did not receive the study article.

Participants by arm

ArmCount
All Subjects
All enrolled subjects who received study lenses.
100
Total100

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1Withdrawal by Subject01

Baseline characteristics

CharacteristicAll Subjects
Age, Continuous25.07 years
STANDARD_DEVIATION 4.879
Region of Enrollment
United States
100 participants
Sex: Female, Male
Female
100 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1000 / 100
serious
Total, serious adverse events
0 / 1000 / 100

Outcome results

Primary

Subject Reported Overall Lens Comfort Using the Contact Lens User Evaluation (CLUE) Questionnaire

The overall lens comfort was assessed using the CLUE questionnaire after 7-9 days of follow-up.The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Time frame: After 7 to 9 days of lens wear

Population: Analysis was conducted on subjects who successfully complete the study without a protocol deviation affecting at least one primary endpoint.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
EAPVPDESubject Reported Overall Lens Comfort Using the Contact Lens User Evaluation (CLUE) Questionnaire53.61 units on a scaleStandard Error 2.201
EADESubject Reported Overall Lens Comfort Using the Contact Lens User Evaluation (CLUE) Questionnaire48.91 units on a scaleStandard Error 2.197
Comparison: The alternative hypothesis is that etafilcon A with PVP lenses is non-inferior to etafilcon A control lenses for the Overall Lens Comfort at 7-9 days of follow-up.95% CI: [-0.79, 10.19]Mixed Models Analysis
Primary

Subject Reported Overall Lens Handling Using the Contact Lens User Evaluation (CLUE) Questionnaire

The overall lens handling was assessed using the CLUE questionnaire after 7-9 days of follow-up. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Time frame: After 7 to 9 days of lens wear

Population: Analysis was conducted on subjects who successfully complete the study without a protocol deviation affecting at least one primary endpoint.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
EAPVPDESubject Reported Overall Lens Handling Using the Contact Lens User Evaluation (CLUE) Questionnaire61.21 units on a scaleStandard Error 1.847
EADESubject Reported Overall Lens Handling Using the Contact Lens User Evaluation (CLUE) Questionnaire51.77 units on a scaleStandard Error 1.842
Comparison: Ho: The test lens is non-inferior to the active comparator lens for Handling at 7-9 days follow-up.95% CI: [5.81, 13.07]Mixed Models Analysis
Primary

Subject Reported Overall Quality of Lens Vision Using the Contact Lens User Evaluation (CLUE) Questionnaire

The overall quality of lens vision was assessed using the CLUE questionnaire after 7-9 days of follow-up. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range from 0-120.

Time frame: After 7 to 9 days of lens wear

Population: Analysis was conducted on subjects who successfully complete the study without a protocol deviation affecting at least one primary endpoint.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
EAPVPDESubject Reported Overall Quality of Lens Vision Using the Contact Lens User Evaluation (CLUE) Questionnaire54.06 units on a scaleStandard Error 2.538
EADESubject Reported Overall Quality of Lens Vision Using the Contact Lens User Evaluation (CLUE) Questionnaire53.06 units on a scaleStandard Error 2.537
Comparison: The alternative hypothesis is that etafilcon A with PVP lenses is non-inferior to etafilcon A control lenses for the Overall Quality of Lens Vision at 7-9 days of follow-up.95% CI: [-3.2, 5.2]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026